Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.
The drug semaglutide has been linked to a lower risk of alcoholism before, but now we have strong evidence that it really ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback